Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes

Michael J. Hassett, Huanxi Li, Harold J. Burstein, Rinaa S. Punglia

2020Breast Cancer Research and Treatment33 citationsDOI

Topics & Concepts

PertuzumabTrastuzumabMedicineBreast cancerDocetaxelOncologyInternal medicineNeoadjuvant therapyTrastuzumab emtansineQuality-adjusted life yearTaxaneCancerCost effectivenessRisk analysis (engineering)HER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies